LION BIOTECHNOLOGIES INC - COM (LBIO)

CUSIP: 53619R102

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
25,887,185
Share change
+17,036,421
Total reported value
$313,492,000
Price per share
$12.11
Number of holders
50
Value change
+$206,309,035
Number of buys
47
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 53619R102?
CUSIP 53619R102 identifies LBIO - LION BIOTECHNOLOGIES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LION BIOTECHNOLOGIES INC - COM (LBIO) as of Q1 2015

As of 31 Mar 2015, LION BIOTECHNOLOGIES INC - COM (LBIO) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,887,185 shares. The largest 10 holders included FMR LLC, Ayer Capital Management, LP, PERCEPTIVE ADVISORS LLC, venBio Select Advisor LLC, BAKER BROS. ADVISORS LP, QVT Financial LP, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, and Longwood Capital Partners LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.